Chemotherapy-induced peripheral neuropathy

Two doses of psilocybin protected mouse nerves through six rounds of cisplatin

The protection ran through the same serotonin receptor that carries the hallucinations, though a non-hallucinogenic compound worked too, and a randomised trial in about 80 patients is due to start in November.